Development
Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 92.71M | 62.56M | 35.16M | 17.86M | -81.44M |
| Total Depreciation and Amortization | 145.84M | 143.01M | 142.40M | 141.50M | 141.15M |
| Total Amortization of Deferred Charges | 4.25M | 4.25M | 4.25M | 4.25M | 4.13M |
| Total Other Non-Cash Items | 56.65M | 64.50M | 51.94M | 12.20M | 84.54M |
| Change in Net Operating Assets | -24.05M | 3.51M | 81.12M | 97.95M | 22.77M |
| Cash from Operations | 275.40M | 277.82M | 314.88M | 273.76M | 171.16M |
| Capital Expenditure | -179.44M | -190.86M | -178.65M | -154.34M | -124.53M |
| Sale of Property, Plant, and Equipment | 10.55M | 8.07M | 14.38M | 14.37M | 3.53M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.00M | -45.63M | -55.58M | -46.36M | -889.00K |
| Cash from Investing | -214.89M | -228.42M | -219.86M | -186.33M | -121.89M |
| Total Debt Issued | 526.12M | 596.93M | 576.53M | 70.03M | 190.87M |
| Total Debt Repaid | -475.88M | -476.23M | -476.52M | -72.09M | -161.85M |
| Issuance of Common Stock | -- | -- | -- | -- | 62.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -40.00M | -40.00M | -10.00M | -10.00M | -100.00K |
| Other Financing Activities | -67.61M | -78.92M | -66.74M | -61.72M | -48.68M |
| Cash from Financing | -57.37M | 1.79M | 23.26M | -73.78M | -19.69M |
| Foreign Exchange rate Adjustments | -3.77M | -4.08M | -4.37M | -1.08M | -2.94M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -626.00K | 47.10M | 113.91M | 12.58M | 26.63M |